Loading live market data…

Aligos Therapeutics, Inc.

NASDAQ:ALGS

$6.105 USD

-$0.26 (-4.01%)

Volume
102.51K
Average Volume
289.73K
Market Capitalization
$37.78M
P/E Ratio
-0.70
Dividend Yield
0.00%
Price Target
$20.00
Year High
$13.69
Year Low
$4.80
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.56

ALGS Estimated and Actual Revenue by Quarter

ALGS Estimated and Actual EPS by Quarter

ALGS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -5.52M -5.52M -5.52M -5.52M -5.52M -5.52M
2027-09-30 3 -275K -275K -275K -275K -275K -275K
2027-06-30 3 -275K -275K -275K -275K -275K -275K
2027-03-31 3 -275K -275K -275K -275K -275K -275K
2026-12-31 5 -537.5K -537.5K -537.5K -537.5K -537.5K -537.5K
2026-09-30 6 -600K -600K -600K -600K -600K -600K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 -11.11M -11.11M -11.11M 28.38M 28.38M 28.38M
2027-09-30 3 -12.54M -12.54M -12.54M 1.41M 1.41M 1.41M
2027-06-30 3 -12.46M -12.46M -12.46M 1.41M 1.41M 1.41M
2027-03-31 3 -15.97M -15.97M -15.97M 1.41M 1.41M 1.41M
2026-12-31 5 -19.79M -19.79M -19.79M 2.76M 2.76M 2.76M
2026-09-30 6 -30.72M -15.07M -22.94M 3.08M 3.08M 3.08M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 5.52M 5.52M 5.52M 1 -1.0675 -1.0675 -1.0675
2027-09-30 3 275K 275K 275K 1 -1.205 -1.205 -1.205
2027-06-30 3 275K 275K 275K 1 -1.1975 -1.1975 -1.1975
2027-03-31 3 275K 275K 275K 1 -1.535 -1.535 -1.535
2026-12-31 5 537.5K 537.5K 537.5K 1 -1.90251 -1.90251 -1.90251
2026-09-30 6 600K 600K 600K 3 -2.9526 -1.44827 -2.20511